| Ytd | -30.21% | |
| 1y | -60.53% |
| Open | 3.77 | Prev Close | 3.69 | Low | 3.57 | High | 3.80 | Mkt Cap | 1.21B |
| Vol | 882.97K | Avg Vol | 678.46K | EPS | -0.29 | P/E | N/A | Forward P/E | 14.80 |
| Beta | 0.21 | Short Ratio | 4.87 | Inst. Own | 5.97% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-06 | 50-d Avg | 3.56 | 200-d Avg | 4.98 | 1yr Est | 14.60 |
— $75 million additional term loan facility maturing December 31, 2027, led by GoldenTree Asset Mana
REYKJAVIK, ICELAND (July 1, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology compan
US stock futures up 0.1%, Dave and Buster's (PLAY) down 13.4% pre-market due to lower earnings;
HITI rose sharply in pre-market trading on strong Q2 results and continued to rise after market open
Alvotech (NASDAQ:ALVO, ALVO-SDB))) ("Alvotech" or the "Company"), a global biotechno